openPR Logo
Press release

Natural Killer Cells Therapies- Competitive Landscape, Technology and Pipeline Analysis, 2017

05-11-2017 10:41 AM CET | Health & Medicine

Press release from: DelveInsight Business Research

Natural Killer Cells Therapies- Competitive Landscape,

DelveInsight Report, “Natural Killer Cells Therapies- Competitive Landscape, Technology and Pipeline Analysis, 2017”, emphasizes on the currently active NK cell products in research and development.

The Report covers 20+ companies, which are active in this field with 40+ products and many different technologies. This report covers NK cell-based therapies along with drugs that augment (enhance or activate) the NK cells. The Report provides in-depth analysis of the Natural Killer Cell-based therapies profiles along with the augmenting therapies covering their pre-clinical and clinical studies, collaborations details and deal values, Technologies and Targeted antigens. The Report provides the NK Cell-based therapies licensing opportunities, acquisitions, market drivers and barriers followed by SWOT Analysis.

Reports Highlights:

NK cell Therapy Pipeline scenario which includes NK cell therapies and NK cell augmenting therapies.

Collaborations & partnering deals

Current Prominent Research Areas and Key Players

Pipeline product profiles NK Cell therapy Technologies and NK cell Augmenting Therapies

Licensing opportunities

Market Drivers and Barriers

Scope

Overview of the global NK cell therapy pipeline scenario, products, and associated companies information

Coverage of global NK cell therapies and drugs that enhance the activity of NK under development

Competitive landscape of products for key players and related indications

Coverage of licensors, collaborators and development partners, deal terms and deal values estimation

Pipeline analysis across different phases, emerging trends and comparative analysis of pipeline products with detailed clinical profiles, mechanism of action, route of administration and molecule type, along with product development activities

Highlights of licensing & collaboration opportunities and funding details

Highlights of latest NK cell therapy technologies and NK cell augmenting therapies and innovative companies

Key topics covered include strategic competitor assessment, barriers and drivers in the market along with SWOT analysis

To know more please click this link https://www.delveinsight.com/natural-killer-cells-therapies-competitive-landscape-technology-and-pipeline-analysis-2017-11092-p.php

DelveInsight is a Business Consultant company and serves as a Knowledge partner across the value chain of Pharmaceutical Industry. With the use of proprietary databases and analytical models, DelveInsight provides cutting-edge market and pipeline analysis and API intelligence across all therapy areas to the Pharma and biotech sector, helping clients to quantify market events and evaluate their impact on the valuation of products, portfolios, and companies.

DelveInsight business research,

A20, Sector 7, Near to Maxfort. School, Dwarka

New Delhi-110077, India

Tel: +91-11-4568 9769 | +91 9650213330

Email: info@delveinsight.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Natural Killer Cells Therapies- Competitive Landscape, Technology and Pipeline Analysis, 2017 here

News-ID: 532223 • Views:

More Releases from DelveInsight Business Research

NLRP3 Protein Inhibitors Pipeline Expands With 20+ Companies Advancing 25+ Therapies, Reveals DelveInsight's Clinical and Developmental Analysis
NLRP3 Protein Inhibitors Pipeline Expands With 20+ Companies Advancing 25+ Thera …
DelveInsight's latest publication, "NLRP3 Protein Inhibitors Pipeline Insight 2025," presents an in-depth evaluation of more than 20 companies and 25 investigational therapies advancing within the NLRP3 Protein Inhibitors development landscape. The report features detailed profiles of both clinical- and preclinical-stage candidates, along with an assessment of therapeutic approaches by product category, development phase, route of administration, and molecule type. Additionally, the analysis highlights inactive or discontinued programs in this domain. Explore
Global Clostridium Difficile Infections Pipeline Expands With 20+ Companies Advancing 22+ Therapies, Reveals DelveInsight's Clinical and Developmental Analysis
Global Clostridium Difficile Infections Pipeline Expands With 20+ Companies Adva …
DelveInsight's report, "Clostridium Difficile Infections Pipeline Insight, 2025," delivers an extensive overview of the current clinical development status and future growth opportunities within the CDI market. The report offers a comprehensive commercial and clinical analysis of pipeline therapies, spanning from preclinical stages to marketed products. It includes detailed drug profiles covering mechanisms of action, clinical data, regulatory milestones, and product development updates such as technological innovations, collaborations, mergers and acquisitions, funding
Global Urticaria Pipeline Expands With 20+ Companies Advancing 25+ Therapies, Reveals DelveInsight's Clinical and Developmental Analysis
Global Urticaria Pipeline Expands With 20+ Companies Advancing 25+ Therapies, Re …
DelveInsight's "Urticaria Pipeline Insight, 2025" report provides an in-depth overview of the current landscape of clinical development and future growth potential within the Urticaria market. The report delivers a comprehensive commercial and clinical analysis of pipeline therapies, spanning preclinical research to marketed products. It offers detailed drug profiles covering mechanisms of action, clinical study updates, regulatory milestones, and product development activities, including technology platforms, partnerships, collaborations, acquisitions, funding, designations, and other
Global Neurofibromatosis Type 2 Pipeline Expands With 5+ Companies Advancing 5+ Therapies, Reveals DelveInsight's Clinical and Developmental Analysis
Global Neurofibromatosis Type 2 Pipeline Expands With 5+ Companies Advancing 5+ …
According to DelveInsight's analysis, the global Neurofibromatosis Type 2 (NF2) pipeline consists of more than five leading companies actively advancing over five therapeutic candidates. The assessment includes a comprehensive review of ongoing clinical trials, therapy mechanisms, routes of administration, and recent development activities. DelveInsight's "Neurofibromatosis Type 2 Pipeline Insight, 2025" report delivers an extensive overview of the current clinical landscape and future growth potential across the Neurofibromatosis Type 2 market. The

All 5 Releases


More Releases for Cell

Cell Sorting Market Accelerates as Cell Therapy, Immuno-Oncology & Single-Cell R …
The rising focus on precision medicine, immunotherapy, and advanced cell-based research is driving the global cell sorting market into a high-growth phase. With expanding applications in stem cell therapy, CAR-T manufacturing, cancer immunology, and single-cell genomics, demand for accurate, high-purity cell isolation systems is stronger than ever. This release highlights key market trends, segmentation insights, technological innovations, and the factors shaping the future of cell sorting. Download Full PDF Sample Copy
Cell Isolation Cell Separation Market Size Analysis by Application, Type, and Re …
According to Market Research Intellect, the global Cell Isolation Cell Separation market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period. The market for cell isolation and separation is expanding rapidly as a result of sophisticated biotechnological
Cell Free Protein Synthesis Market Beyond the Cell: Revolutionizing Protein Prod …
Cell-Free Protein Synthesis Market to reach over USD 457.13 Mn by the year 2031 - Exclusive Report by InsightAce Analytic "Cell-Free Protein Synthesis Market" in terms of revenue was estimated to be worth $265.94 Mn in 2023 and is poised to reach $457.13 Mn by 2031, growing at a CAGR of 7.20% from 2024 to 2031 according to a new report by InsightAce Analytic. Request for free Sample Pages: https://www.insightaceanalytic.com/request-sample/1445 Current
Cell Expansion Market - Expand the Boundaries of Cell Therapy: Redefine Cell Exp …
Newark, New Castle, USA: The "Cell Expansion Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors Cell Expansion Market: https://www.growthplusreports.com/report/cell-expansion-market/7939 This latest report researches the industry structure, sales, revenue,
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports. This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions. This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer. Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u Top Key Players: - Becton, Dickinson and Company Biospherix EMD Millipore Eppendorf AG Merck KGaA Sartorius AG VWR International Cell culture is a rapidly emerging